The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00481585|
Recruitment Status : Terminated (study team failed to complete timely reviews, study suspended)
First Posted : June 1, 2007
Last Update Posted : February 4, 2014
The objective of the present study is to determine whether or not primary human mammary epithelial cells are competent for use in molecular studies of transepithelial electrophysiology focusing on the function of the tight junction protein claudin 3.
Human breast Tissue will be removed from mastectomy specimens and used as a source to generate epithelial cells for study.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||13 participants|
|Official Title:||The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture|
|Study Start Date :||May 2007|
|Primary Completion Date :||July 2009|
- Cell line data study [ Time Frame: one year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00481585
|United States, New Jersey|
|Hackensack Univeristy Medical Center|
|Hackensack, New Jersey, United States, 07601|
|Principal Investigator:||Erik F Young, Ph.D.||Hackensack University Medical Center|